Daniel John Renouf

机构：BC Cancer Agency, University of British Columbia, Pancreas Centre (Canada) · ORCID：0000-0002-7597-6089

发表论文 520 篇 · 总被引 9505 次 · h-index 43

代表论文

• PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic Cancer (2025 · Journal of Clinical Oncology · 被引 38)
• Neutrophil extracellular trap gene expression signatures identify prognostic and targetable signaling axes for inhibiting pancreatic tumour metastasis (2025 · Communications Biology · 被引 16)
• NeoPancONE: GATA6 expression as a predictor of benefit to peri-operative modified FOLFIRINOX in resectable pancreatic adenocarcinoma (r-PDAC): A multicentre phase II study. (2025 · Journal of Clinical Oncology · 被引 8)
• Whole-genome analysis of an aggressive metastatic pancreatic solid pseudopapillary neoplasm (2025 · npj Precision Oncology · 被引 6)
• The Terry Fox Research Institute Marathon of Hope Cancer Centres Network: A pan-Canadian precision oncology initiative (2025 · Cancer Cell · 被引 4)
• Erratum: PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic Cancer (2025 · Journal of Clinical Oncology · 被引 3)